ALIZIN 30 MG/ML SOLUTION FOR INJECTION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

AGLEPRISTONE

Available from:

Virbac S.A.

ATC code:

QG03XB90

INN (International Name):

AGLEPRISTONE

Dosage:

30 Mg/Ml

Pharmaceutical form:

Solution for Injection

Prescription type:

POM

Therapeutic group:

Canine

Therapeutic area:

Aglepristone

Therapeutic indications:

Hormone

Authorization status:

Authorised

Authorization date:

2004-05-07

Summary of Product characteristics

                                IRISH MEDICINES BOARD ACT 1995, AS AMENDED
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
VPA: 10988/066/001
Case No: 7004829
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
VIRBAC S.A.
VIRBAC 1, 1 ERE AVENUE, 2065 M - L.I.D., BP 27, 06516, CARROS CEDEX, FRANCE
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
ALIZIN 30MG/ML SOLUTION FOR INJECTION
The particulars of which are set out in the attached Schedule. The authorisation is also subject to any special conditions as may be specified in
the Schedule.
The authorisation,unless revoked, shall continue in force from 26/11/2008.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 04/09/2010_
_CRN 7004829_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Alizin 30mg/ml Solution for Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, yellow oily solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs (bitches).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pregnant bitches: induction of abortion up to 45 days after mating.
4.3 CONTRAINDICATIONS
Do not use in dogs with impaired hepatic or renal function, in diabetic animals or in dogs in poor health.
Do not use in d
                                
                                Read the complete document
                                
                            

Search alerts related to this product